相似文献
1
Regulatory T cell function in autoimmune disease.
J Transl Autoimmun. 2021 Oct 30;4:100130. doi: 10.1016/j.jtauto.2021.100130. eCollection 2021.
2
Foxp3+ Helios+ regulatory T cells are expanded in active systemic lupus erythematosus.
Ann Rheum Dis. 2013 Sep 1;72(9):1549-58. doi: 10.1136/annrheumdis-2012-202216. Epub 2012 Dec 21.
3
Foxp3, Regulatory T Cell, and Autoimmune Diseases.
Inflammation. 2017 Feb;40(1):328-339. doi: 10.1007/s10753-016-0470-8.
4
A unique thymus-derived regulatory T cell subset associated with systemic lupus erythematosus.
Arthritis Res Ther. 2020 Apr 21;22(1):88. doi: 10.1186/s13075-020-02183-2.
5
[Regulatory T-cells in systemic lupus erythematosus. IL-2 is decisive for loss of tolerance].
Z Rheumatol. 2016 Apr;75(3):253-64. doi: 10.1007/s00393-016-0060-z.
6
Analysis of FOXP3 regulatory T cell subpopulations in peripheral blood and tissue of patients with systemic lupus erythematosus.
Immunol Res. 2017 Apr;65(2):551-563. doi: 10.1007/s12026-017-8904-4.
7
The effect of autoimmune arthritis treatment strategies on regulatory T-cell dynamics.
Curr Opin Rheumatol. 2013 Mar;25(2):260-7. doi: 10.1097/BOR.0b013e32835d0ee4.
8
Chronic Immune Activation in Systemic Lupus Erythematosus and the Autoimmune PTPN22 Trp Risk Allele Drive the Expansion of FOXP3 Regulatory T Cells and PD-1 Expression.
Front Immunol. 2019 Nov 8;10:2606. doi: 10.3389/fimmu.2019.02606. eCollection 2019.
9
Regulatory T cells in systemic lupus erythematosus.
Eur J Immunol. 2015 Feb;45(2):344-55. doi: 10.1002/eji.201344280. Epub 2014 Dec 15.
10
Low-dose interleukin-2 selectively corrects regulatory T cell defects in patients with systemic lupus erythematosus.
Ann Rheum Dis. 2016 Jul;75(7):1407-15. doi: 10.1136/annrheumdis-2015-207776. Epub 2015 Aug 31.
引用本文的文献
1
Regulatory T Cell Sub-Populations in Patients with Distinct Autoimmune/Inflammatory Diseases With or Without Inborn Errors of Immunity.
Diagnostics (Basel). 2025 Jul 26;15(15):1879. doi: 10.3390/diagnostics15151879.
2
IRAK3 is upregulated in rheumatoid arthritis synovium and delays the onset of experimental arthritis.
Front Immunol. 2025 Apr 30;16:1468341. doi: 10.3389/fimmu.2025.1468341. eCollection 2025.
3
Immunomodulatory interactions between mesenchymal stromal/stem cells and immune cells in psoriasis: therapeutic potential and challenges.
Stem Cell Res Ther. 2025 May 14;16(1):241. doi: 10.1186/s13287-025-04375-6.
4
A Systematic Review of Immune Cell Roles in Breast Cancer Immunotherapy.
Cancer Rep (Hoboken). 2025 May;8(5):e70217. doi: 10.1002/cnr2.70217.
5
The dual role of tissue regulatory T cells in tissue repair: return to homeostasis or fibrosis.
Front Immunol. 2025 Mar 6;16:1560578. doi: 10.3389/fimmu.2025.1560578. eCollection 2025.
6
Conversion of T Effector Cells Into T Regulatory Cells in Type 1 Diabetes/Latent Autoimmune Diabetes of Adults by Inhibiting eIF5A and Notch Pathways.
Immunotargets Ther. 2025 Mar 13;14:205-226. doi: 10.2147/ITT.S504555. eCollection 2025.
7
Regulatory T Cell Metabolism: A Promising Therapeutic Target for Cancer Treatment?
Immune Netw. 2025 Feb 24;25(1):e13. doi: 10.4110/in.2025.25.e13. eCollection 2025 Feb.
8
From promise to practice: CAR T and Treg cell therapies in autoimmunity and other immune-mediated diseases.
Front Immunol. 2024 Dec 4;15:1509956. doi: 10.3389/fimmu.2024.1509956. eCollection 2024.
9
Mogamulizumab-Associated Autoimmune Diseases: Insights From FAERS Database Analysis.
Cancer Med. 2024 Dec;13(23):e70478. doi: 10.1002/cam4.70478.
10
Hypoxia in Human Obesity: New Insights from Inflammation towards Insulin Resistance-A Narrative Review.
Int J Mol Sci. 2024 Sep 11;25(18):9802. doi: 10.3390/ijms25189802.
本文引用的文献
1
Regulatory T cells function in established systemic inflammation and reverse fatal autoimmunity.
Nat Immunol. 2021 Sep;22(9):1163-1174. doi: 10.1038/s41590-021-01001-4. Epub 2021 Aug 23.
2
Effects of a low-dose IL-2 treatment in HLA-B27 transgenic rat model of spondyloarthritis.
Arthritis Res Ther. 2021 Jul 16;23(1):193. doi: 10.1186/s13075-021-02559-y.
3
Duplication of the IL2RA locus causes excessive IL-2 signaling and may predispose to very early onset colitis.
Mucosal Immunol. 2021 Sep;14(5):1172-1182. doi: 10.1038/s41385-021-00423-5. Epub 2021 Jul 5.
4
Conversion of T Follicular Helper Cells to T Follicular Regulatory Cells by Interleukin-2 Through Transcriptional Regulation in Systemic Lupus Erythematosus.
Arthritis Rheumatol. 2021 Jan;73(1):132-142. doi: 10.1002/art.41457. Epub 2020 Nov 10.
5
Bacterial metabolism of bile acids promotes generation of peripheral regulatory T cells.
Nature. 2020 May;581(7809):475-479. doi: 10.1038/s41586-020-2193-0. Epub 2020 Apr 15.
6
Meta-Analysis of Changes in the Number and Proportion of Regulatory T Cells in Patients with Ankylosing Spondylitis.
Biomed Res Int. 2020 Feb 19;2020:8709804. doi: 10.1155/2020/8709804. eCollection 2020.
7
EZH2 deficiency attenuates Treg differentiation in rheumatoid arthritis.
J Autoimmun. 2020 Mar;108:102404. doi: 10.1016/j.jaut.2020.102404. Epub 2020 Jan 15.
8
The role of regulatory T cells in graft-versus-host disease management.
Expert Rev Hematol. 2020 Feb;13(2):141-154. doi: 10.1080/17474086.2020.1709436. Epub 2020 Jan 11.
9
Involvement of Tumor Necrosis Factor Receptor Type II in FoxP3 Stability and as a Marker of Treg Cells Specifically Expanded by Anti-Tumor Necrosis Factor Treatments in Rheumatoid Arthritis.
Arthritis Rheumatol. 2020 Apr;72(4):576-587. doi: 10.1002/art.41134. Epub 2020 Feb 20.
10
Efficacy and safety of low-dose IL-2 in the treatment of systemic lupus erythematosus: a randomised, double-blind, placebo-controlled trial.
Ann Rheum Dis. 2020 Jan;79(1):141-149. doi: 10.1136/annrheumdis-2019-215396. Epub 2019 Sep 19.
Zotero 插件